Related references
Note: Only part of the references are listed.Extracellular vesicles-derived OncomiRs mediate communication between cancer cells and cancer-associated hepatic stellate cells in hepatocellular carcinoma microenvironment
Jiang Li et al.
CARCINOGENESIS (2020)
Liver stiffness as a predictor of hepatocellular carcinoma behavior in patients with hepatitis C related liver cirrhosis
Sameh A. Lashen et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2020)
Activated hepatic stellate cells promote angiogenesis in hepatocellular carcinoma by secreting angiopoietin-1
Nan Lin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
Sorafenib-Loaded Nanoparticles Based on Biodegradable Dendritic Polymers for Enhanced Therapy of Hepatocellular Carcinoma
Zihuang Li et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Quiescent hepatic stellate cells induce toxicity and sensitivity to doxorubicin in cancer cells through a caspase-independent cell death pathway: Central role of apoptosis-inducing factor
Dola Das et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Hepatic Stellate Cell: A Potential Target for Hepatocellular Carcinoma
Mengna Wu et al.
CURRENT MOLECULAR PHARMACOLOGY (2020)
A Positive Feedback Loop of TET3 and TGF-β1 Promotes Liver Fibrosis
Yetao Xu et al.
CELL REPORTS (2020)
Hepatic stellate cells promote the progression of hepatocellular carcinoma through microRNA-1246-RORα-Wnt/β-Catenin axis
Jin-Long Huang et al.
CANCER LETTERS (2020)
Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma
Tatjana Seitz et al.
SCIENTIFIC REPORTS (2020)
Defined p16High Senescent Cell Types Are Indispensable for Mouse Healthspan
Laurent Grosse et al.
CELL METABOLISM (2020)
Resveratrol as a Tumor-Suppressive Nutraceutical Modulating Tumor Microenvironment and Malignant Behaviors of Cancer
Youngjin Han et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The origin of exosomal miR-1246 in human cancer cells
Yi-Fan Xu et al.
RNA BIOLOGY (2019)
ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice
Weiguo Fan et al.
GASTROENTEROLOGY (2019)
An imbalance between stellate cells and γδT cells contributes to hepatocellular carcinoma aggressiveness and recurrence
Bao-Yong Zhou et al.
HEPATOLOGY INTERNATIONAL (2019)
Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis
Dariusz Lachowski et al.
SCIENTIFIC REPORTS (2019)
MicroRNA-212-3p inhibits the Proliferation and Invasion of Human Hepatocellular Carcinoma Cells by Suppressing CTGF expression
Jian-qing Chen et al.
SCIENTIFIC REPORTS (2019)
The Roles of Liver-Resident Lymphocytes in Liver Diseases
Yanan Wang et al.
FRONTIERS IN IMMUNOLOGY (2019)
Current Treatment Landscape for Advanced Hepatocellular Carcinoma: Patient Outcomes and the Impact on Quality of Life
Daneng Li et al.
CANCERS (2019)
Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma
Zeli Yin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities
Chen Lu et al.
MOLECULAR CANCER (2019)
LBA3IMbrave150: Efficacy and safety results from a ph III study evaluating atezolizumab (atezo) + bevacizumab (bev) vs sorafenib (Sor) as first treatment (tx) for patients (pts) with unresectable hepatocellular carcinoma (HCC)
A-L Cheng et al.
ANNALS OF ONCOLOGY (2019)
The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma
Cristian Scheau et al.
ANALYTICAL CELLULAR PATHOLOGY (2019)
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019
Bedair Dewidar et al.
CELLS (2019)
Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases
Daphne van der Heide et al.
FRONTIERS IN IMMUNOLOGY (2019)
CTGF Mediates Tumor-Stroma Interactions between Hepatoma Cells and Hepatic Stellate Cells to Accelerate HCC Progression
Yuki Makino et al.
CANCER RESEARCH (2018)
Treatment-damaged hepatocellular carcinoma promotes activities of hepatic stellate cells and fibrosis through GDF15
Gang Dong et al.
EXPERIMENTAL CELL RESEARCH (2018)
Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease
Joanne E. Murphy-Ullrich et al.
MATRIX BIOLOGY (2018)
Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development
Yun-Chieh Sung et al.
THERANOSTICS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Type 3 innate lymphoid cell: a new player in liver fibrosis progression
Siqi Wang et al.
CLINICAL SCIENCE (2018)
Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts
Yuan Zhou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Update in global trends and aetiology of hepatocellular carcinoma
Prashanth Rawla et al.
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY (2018)
Role of thrombospondin 1 in liver diseases
Yanzhang Li et al.
HEPATOLOGY RESEARCH (2017)
Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy
Maryam Tahmasebi Birgani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Lysosome-mediated degradation of a distinct pool of lipid droplets during hepatic stellate cell activation
Maidina Tuohetahuntila et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Trends in the Mortality of Hepatocellular Carcinoma in the United States
Eliza W. Beal et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2017)
Liver sinusoidal endothelial cells: Physiology and role in liver diseases
Johanne Poisson et al.
JOURNAL OF HEPATOLOGY (2017)
Resveratrol inhibits hepatocellular carcinoma progression driven by hepatic stellate cells by targeting Gli-1
Yu Yan et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
MicroRNA-212 functions as a tumor-suppressor in human non-small cell lung cancer by targeting SOX4
Tingting Tang et al.
ONCOLOGY REPORTS (2017)
Liver Sinusoidal Endothelial Cell: An Update
Laurie D. DeLeve et al.
SEMINARS IN LIVER DISEASE (2017)
MicroRNA-212 inhibits the proliferation, migration and invasion of renal cell carcinoma by targeting X-linked inhibitor of apoptosis protein (XIAP)
Chaohui Gu et al.
ONCOTARGET (2017)
Agrin para-secreted by PDGF-activated human hepatic stellate cells promotes hepatocarcinogenesis in vitro and in vivo
Xing Lv et al.
ONCOTARGET (2017)
Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients
Jijing Shi et al.
SCIENTIFIC REPORTS (2017)
SECs (Sinusoidal Endothelial Cells), Liver Microenvironment, and Fibrosis
Vaishaali Natarajan et al.
BIOMED RESEARCH INTERNATIONAL (2017)
miR-151a induces partial EMT by regulating E-cadherin in NSCLC cells
I. Daugaard et al.
ONCOGENESIS (2017)
Hepatic stellate cells as key target in liver fibrosis
Takaaki Higashi et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Components of the hepatocellular carcinoma microenvironment and their role in tumor progression
M. V. Novikova et al.
BIOCHEMISTRY-MOSCOW (2017)
Comparison of hepatocellular carcinoma in Eastern versus Western populations
Su Pin Choo et al.
CANCER (2016)
NKT cell subsets as key participants in liver physiology and pathology
Keya Bandyopadhyay et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Impact of the physical microenvironment on tumor progression and metastasis
Fabian Spill et al.
CURRENT OPINION IN BIOTECHNOLOGY (2016)
TGF-β signalling and liver disease
Isabel Fabregat et al.
FEBS JOURNAL (2016)
Hepatic stellate cell transdifferentiation involves genome-wide remodeling of the DNA methylation landscape
Agata Page et al.
JOURNAL OF HEPATOLOGY (2016)
The heterogeneity of human CD127+ innate lymphoid cells revealed by single-cell RNA sequencing
Asa K. Bjorklund et al.
NATURE IMMUNOLOGY (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
Activation of PPARγ/P53 signaling is required for curcumin to induce hepatic stellate cell senescence
H. Jin et al.
CELL DEATH & DISEASE (2016)
Decoding the Secret of Cancer by Means of Extracellular Vesicles
Nobuyoshi Kosaka
JOURNAL OF CLINICAL MEDICINE (2016)
IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner
Hitoshi Nishizawa et al.
SCIENTIFIC REPORTS (2016)
Hepatic stellate cells: central modulators of hepatic carcinogenesis
Alexandra I. Thompson et al.
BMC GASTROENTEROLOGY (2015)
Transfer of microRNAs by extracellular membrane microvesicles: a nascent crosstalk model in tumor pathogenesis, especially tumor cell-microenvironment interactions
Li Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Activated hepatic stellate cells promote angiogenesis via interleukin-8 in hepatocellular carcinoma
Bing Zhu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce et al.
SCIENCE (2015)
Integrative miRNA and Gene Expression Profiling Analysis of Human Quiescent Hepatic Stellate Cells
Mar Coll et al.
SCIENTIFIC REPORTS (2015)
Angiogenin Secretion From Hepatoma Cells Activates Hepatic Stellate Cells To Amplify A Self-Sustained Cycle Promoting Liver Cancer
Cristina Barcena et al.
SCIENTIFIC REPORTS (2015)
Natural killer T cells in liver injury, inflammation and cancer
Hua Wang et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2015)
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
Christopher J. Cheng et al.
NATURE (2015)
MicroRNA regulons in tumor microenvironment
H. I. Suzuki et al.
ONCOGENE (2015)
Targeting the tumor stroma in hepatocellular carcinoma
Femke Heindryckx et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
IL-20 and IL-20R1 Antibodies Protect Against Liver Fibrosis
Yi-Shu Chiu et al.
HEPATOLOGY (2014)
Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: Evidence for stromal induction of hepatocellular carcinoma
Jocelyn H. Wright et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Stellate cells and the development of liver cancer: Therapeutic potential of targeting the stroma
Cedric Coulouarn et al.
JOURNAL OF HEPATOLOGY (2014)
Hepatic stellate cells promote tumor progression by enhancement of immunosuppressive cells in an orthotopic liver tumor mouse model
Wenxiu Zhao et al.
LABORATORY INVESTIGATION (2014)
Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever
Vinicio Carloni et al.
LIVER INTERNATIONAL (2014)
Activated hepatic stellate cells promote hepatocellular carcinoma cell migration and invasion via the activation of FAK-MMP9 signaling
Shaoshan Han et al.
ONCOLOGY REPORTS (2014)
Angiogenesis and the Tumor Microenvironment: Vascular Endothelial Growth Factor and Beyond
Kriti Mittal et al.
SEMINARS IN ONCOLOGY (2014)
Expression and significance of MMP2 and HIF-1α in hepatocellular carcinoma
Bin Wang et al.
ONCOLOGY LETTERS (2014)
The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells
Ching-Chuan Hsieh et al.
BLOOD (2013)
Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
Virginia Hernandez-Gea et al.
GASTROENTEROLOGY (2013)
Transforming Growth Factor-β (TGF-β)-mediated Connective Tissue Growth Factor (CTGF) Expression in Hepatic Stellate Cells Requires Stat3 Signaling Activation
Yan Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Hepatic stellate cells in liver development, regeneration, and cancer
Chunyue Yin et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis
Alexander Wehr et al.
JOURNAL OF IMMUNOLOGY (2013)
Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells
Yangqing Huang et al.
PLOS ONE (2013)
Therapy for Fibrotic Diseases: Nearing the Starting Line
Scott L. Friedman et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Concise Review: Growth Differentiation Factor 15 in Pathology: A Clinical Role?
Jill Corre et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Hepatocyte-Stellate Cell Cross-Talk in the Liver Engenders a Permissive Inflammatory Microenvironment That Drives Progression in Hepatocellular Carcinoma
Cedric Coulouarn et al.
CANCER RESEARCH (2012)
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
Hashem B. El-Serag
GASTROENTEROLOGY (2012)
NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis
Chamutal Gur et al.
GUT (2012)
NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease
Wing-Kin Syn et al.
GUT (2012)
Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis
Benjamin Kraemer et al.
HEPATOLOGY (2012)
Fibrosis-dependent mechanisms of hepatocarcinogenesis
David Y. Zhang et al.
HEPATOLOGY (2012)
NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner
Andreas Glaessner et al.
LABORATORY INVESTIGATION (2012)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats
Er-Bao Bian et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Negative Regulation of Schistosoma japonicum Egg-Induced Liver Fibrosis by Natural Killer Cells
Xin Hou et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis
Kenneth E. Lipson et al.
FIBROGENESIS & TISSUE REPAIR (2012)
Mechanisms of hepatic fibrogenesis
Ursula E. Lee et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
Epigenetic regulation of CIITA expression in human T-cells
Marja C. J. A. van Eggermond et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Roles for CCN2 in normal physiological processes
Faith Hall-Glenn et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Increasing Prevalence of HCC and Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
Fasiha Kanwal et al.
GASTROENTEROLOGY (2011)
Amelioration of hepatic fibrosis by NK cell activation
Nidal Muhanna et al.
GUT (2011)
Epimorphin Promotes Human Hepatocellular Carcinoma Invasion and Metastasis Through Activation of Focal Adhesion Kinase/Extracellular Signal-Regulated Kinase/Matrix Metalloproteinase-9 Axis
Ya-Li Jia et al.
HEPATOLOGY (2011)
Suppression of Innate Immunity (Natural Killer Cell/Interferon-γ) in the Advanced Stages of Liver Fibrosis in Mice
Won-Il Jeong et al.
HEPATOLOGY (2011)
Interleukin-22 Promotes Human Hepatocellular Carcinoma by Activation of STAT3
Runqiu Jiang et al.
HEPATOLOGY (2011)
Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice
Takahiro Kodama et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets
Joon-Il Jun et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153
N. Wu et al.
NEOPLASMA (2011)
MeCP2 controls the expression of RASAL1 in the hepatic fibrosis in rats
Hui Tao et al.
TOXICOLOGY (2011)
FAK is involved in invasion and metastasis of hepatocellular carcinoma
Jing-Song Chen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
The changing pattern of epidemiology in hepatocellular carcinoma
Helena Nordenstedt et al.
DIGESTIVE AND LIVER DISEASE (2010)
Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting
Achilleas D. Theocharis et al.
FEBS JOURNAL (2010)
Ageing, telomeres, senescence, and liver injury
Matthew Hoare et al.
JOURNAL OF HEPATOLOGY (2010)
Insulin-like growth factor binding protein 5 enhances survival of LX2 human hepatic stellate cells
Aleksandar Sokolovic et al.
FIBROGENESIS & TISSUE REPAIR (2010)
MicroRNAs in Cancer
Ramiro Garzon et al.
ANNUAL REVIEW OF MEDICINE (2009)
Hepatic stellate cell lipid droplets: A specialized lipid droplet for retinoid storage
William S. Blaner et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2009)
p53 controls prostate-derived factor/macrophage inhibitory cytokine/NSAID-activated gene expression in response to cell density, DNA damage and hypoxia through diverse mechanisms
Julie A. Kelly et al.
CANCER LETTERS (2009)
Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma
Thomas Amann et al.
CANCER SCIENCE (2009)
The tumor suppressor protein PTEN inhibits rat hepatic stellate cell activation
Motoki Takashima et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Senescence of activated stellate cells limits liver fibrosis
Valery Krizhanovsky et al.
CELL (2008)
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells
Bastian Hoechst et al.
GASTROENTEROLOGY (2008)
Mechanisms of hepatic fibrogenesis
Scott L. Friedman
GASTROENTEROLOGY (2008)
Cellular and molecular mechanisms of fibrosis
T. A. Wynn
JOURNAL OF PATHOLOGY (2008)
Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer
William M. Merritt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver
Scott L. Friedman
PHYSIOLOGICAL REVIEWS (2008)
A chemical method for fast and sensitive detection of DNA synthesis in vivo
Adrian Salic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function
Ping-Ying Pan et al.
BLOOD (2008)
Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1
Svetlana Radaeva et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Cellular senescence in cancer and aging
Manuel Collado et al.
CELL (2007)
Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma
John K. Wiencke et al.
NEURO-ONCOLOGY (2007)
Platelet-derived growth factor receptor-α:: a novel therapeutic target in human hepatocellular cancer
Peggy Stock et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Chronic viral hepatitis and hepatocellular carcinoma
Yagil Barazani et al.
WORLD JOURNAL OF SURGERY (2007)
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients
Junliang Fu et al.
GASTROENTEROLOGY (2007)
Lymphocyte-hepatic stellate cell proximity suggests a direct interaction
N. Muhanna et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
microRNAs as oncogenes and tumor suppressors
Baohong Zhang et al.
DEVELOPMENTAL BIOLOGY (2007)
Cellular senescence: when bad things happen to good cells
Judith Campisi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
The role of cytokines in hepatocellular carcinoma
Anuradha Budhu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment
Anuradha Budhu et al.
CANCER CELL (2006)
Epigenetic silencing of the PTEN gene in melanoma
Alireza Mirmohammadsadegh et al.
CANCER RESEARCH (2006)
Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC
Alaa Melhem et al.
JOURNAL OF HEPATOLOGY (2006)
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
Gregory L. Armstrong et al.
ANNALS OF INTERNAL MEDICINE (2006)
The liver as an immunological organ
V Racanelli et al.
HEPATOLOGY (2006)
Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners
S Radaeva et al.
GASTROENTEROLOGY (2006)
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
G D'Amico et al.
JOURNAL OF HEPATOLOGY (2006)
TGF-beta/Smad signaling in the injured liver
K Breitkopf et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2006)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Thrombospondin 1 acts as a strong promoter of transforming growth factor β effects via two distinct mechanisms in hepatic stellate cells
K Breitkopf et al.
GUT (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Reduced expression of Dicer associated with poor prognosis in lung cancer patients
Y Karube et al.
CANCER SCIENCE (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Prostaglandin E2 inhibits transforming growth factor β1-mediated induction of collagen α1(I) in hepatic stellate cells
AY Hui et al.
JOURNAL OF HEPATOLOGY (2004)
Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice
MC Yu et al.
HEPATOLOGY (2004)
Promoter methylation profiling of 30 genes in human malignant melanoma
J Furuta et al.
CANCER SCIENCE (2004)
Dominant-negative soluble PDGF-β receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis
E Borkham-Kamphorst et al.
LABORATORY INVESTIGATION (2004)
被撤回的出版物: Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia (Retracted article. See vol. 113, pg. 2370, 2009)
J Roman-Gomez et al.
BLOOD (2004)
Interactions between hepatic stellate cells and the immune system
JJ Maher
SEMINARS IN LIVER DISEASE (2001)
The formation of capsule and septum in human hepatocellular carcinoma
M Ishizaki et al.
VIRCHOWS ARCHIV (2001)
Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
SL Friedman
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
